Alterations in plasma transforming growth factor β in normoalbuminuric type 1 and type 2 diabetic patients

Sami T. Azar, Ibrahim Salti, Mira S. Zantout, Stella Major

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Transforming growth factor β (TGF-β) is an immunosuppressor. It plays a role in regulating cell proliferation, and deletion of its gene in transgenic mice leads to an autoimmune-like disorder. A role of this cytokine has been proposed in the pathogenesis of type 1 diabetes and probably type 2 diabetes. Previous studies had shown an elevated serum level in type 2 diabetes and a reduced serum level in type 1 diabetes; however, these studies did not address the onset of the alterations of TGF-β with regard to the duration of diabetes. In this study, we compared the levels of TGF-β in the serum of groups of patients with type 1 and type 2 diabetes mellitus divided according to the duration of their disease. Twenty-six normoalbuminuric patients with type 1 diabetes and 25 normoalbuminuric patients with type 2 diabetes were divided into three groups according to the onset of their diabetes and were compared with 27 and 15 age-matched normal subjects, respectively. We conclude that in normoalbuminuric patients serum TGF-β levels increased at the onset of type 2 diabetes and remained elevated throughout the disease; they did not change at the onset of type 1 diabetes, however, they started to decrease around 2 yr after the onset of the disease.

Original languageEnglish
Pages (from-to)4680-4682
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume85
Issue number12
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Transforming Growth Factors
Medical problems
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Plasmas
Serum
Gene Deletion
Transgenic Mice
Cell Proliferation
Cytokines
Cell proliferation
Genes

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Alterations in plasma transforming growth factor β in normoalbuminuric type 1 and type 2 diabetic patients. / Azar, Sami T.; Salti, Ibrahim; Zantout, Mira S.; Major, Stella.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 85, No. 12, 2000, p. 4680-4682.

Research output: Contribution to journalArticle

@article{def9dc6228824ca586d7e5b3b38a8d90,
title = "Alterations in plasma transforming growth factor β in normoalbuminuric type 1 and type 2 diabetic patients",
abstract = "Transforming growth factor β (TGF-β) is an immunosuppressor. It plays a role in regulating cell proliferation, and deletion of its gene in transgenic mice leads to an autoimmune-like disorder. A role of this cytokine has been proposed in the pathogenesis of type 1 diabetes and probably type 2 diabetes. Previous studies had shown an elevated serum level in type 2 diabetes and a reduced serum level in type 1 diabetes; however, these studies did not address the onset of the alterations of TGF-β with regard to the duration of diabetes. In this study, we compared the levels of TGF-β in the serum of groups of patients with type 1 and type 2 diabetes mellitus divided according to the duration of their disease. Twenty-six normoalbuminuric patients with type 1 diabetes and 25 normoalbuminuric patients with type 2 diabetes were divided into three groups according to the onset of their diabetes and were compared with 27 and 15 age-matched normal subjects, respectively. We conclude that in normoalbuminuric patients serum TGF-β levels increased at the onset of type 2 diabetes and remained elevated throughout the disease; they did not change at the onset of type 1 diabetes, however, they started to decrease around 2 yr after the onset of the disease.",
author = "Azar, {Sami T.} and Ibrahim Salti and Zantout, {Mira S.} and Stella Major",
year = "2000",
doi = "10.1210/jc.85.12.4680",
language = "English",
volume = "85",
pages = "4680--4682",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - Alterations in plasma transforming growth factor β in normoalbuminuric type 1 and type 2 diabetic patients

AU - Azar, Sami T.

AU - Salti, Ibrahim

AU - Zantout, Mira S.

AU - Major, Stella

PY - 2000

Y1 - 2000

N2 - Transforming growth factor β (TGF-β) is an immunosuppressor. It plays a role in regulating cell proliferation, and deletion of its gene in transgenic mice leads to an autoimmune-like disorder. A role of this cytokine has been proposed in the pathogenesis of type 1 diabetes and probably type 2 diabetes. Previous studies had shown an elevated serum level in type 2 diabetes and a reduced serum level in type 1 diabetes; however, these studies did not address the onset of the alterations of TGF-β with regard to the duration of diabetes. In this study, we compared the levels of TGF-β in the serum of groups of patients with type 1 and type 2 diabetes mellitus divided according to the duration of their disease. Twenty-six normoalbuminuric patients with type 1 diabetes and 25 normoalbuminuric patients with type 2 diabetes were divided into three groups according to the onset of their diabetes and were compared with 27 and 15 age-matched normal subjects, respectively. We conclude that in normoalbuminuric patients serum TGF-β levels increased at the onset of type 2 diabetes and remained elevated throughout the disease; they did not change at the onset of type 1 diabetes, however, they started to decrease around 2 yr after the onset of the disease.

AB - Transforming growth factor β (TGF-β) is an immunosuppressor. It plays a role in regulating cell proliferation, and deletion of its gene in transgenic mice leads to an autoimmune-like disorder. A role of this cytokine has been proposed in the pathogenesis of type 1 diabetes and probably type 2 diabetes. Previous studies had shown an elevated serum level in type 2 diabetes and a reduced serum level in type 1 diabetes; however, these studies did not address the onset of the alterations of TGF-β with regard to the duration of diabetes. In this study, we compared the levels of TGF-β in the serum of groups of patients with type 1 and type 2 diabetes mellitus divided according to the duration of their disease. Twenty-six normoalbuminuric patients with type 1 diabetes and 25 normoalbuminuric patients with type 2 diabetes were divided into three groups according to the onset of their diabetes and were compared with 27 and 15 age-matched normal subjects, respectively. We conclude that in normoalbuminuric patients serum TGF-β levels increased at the onset of type 2 diabetes and remained elevated throughout the disease; they did not change at the onset of type 1 diabetes, however, they started to decrease around 2 yr after the onset of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0034485840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034485840&partnerID=8YFLogxK

U2 - 10.1210/jc.85.12.4680

DO - 10.1210/jc.85.12.4680

M3 - Article

VL - 85

SP - 4680

EP - 4682

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 12

ER -